| NCT02806414 | Rosacea | Drug: Ivermectin | University of California, San Diego|Galderma | Phase 1|Phase 2 | 2016-07-01 | 2016-06-17 |
| NCT02036229 | Demodicidosis|Rosacea | Drug: ivermectin cream 0.5% | Rabin Medical Center | Phase 3 | 2014-02-01 | 2015-01-10 |
| NCT02784743 | Lymphatic Filariasis | Drug: ''albendazole'' and ''ivermectin'' | Centre d'Appui 脿 la lutte contre la Maladie|Malaria Research and Training Center, Bamako, Mali|World Health Organization | Phase 4 | 2001-05-01 | 2016-05-24 |
| NCT00921219 | Healthy | Drug: ivermectin | Johnson & Johnson Consumer and Personal Products Worldwide | Phase 1 | 2005-09-01 | 2011-10-04 |
| NCT00921154 | Healthy | Drug: ivermectin | Johnson & Johnson Consumer and Personal Products Worldwide | Phase 1 | 2005-03-01 | 2011-10-04 |
| NCT00921674 | Healthy | Drug: ivermectin | Johnson & Johnson Consumer and Personal Products Worldwide | Phase 1 | 2005-02-01 | 2011-10-04 |
| NCT02963324 | Malaria | Drug: Ivermectin | University Hospital, Basel, Switzerland | Phase 1 | 2016-11-01 | 2017-01-31 |
| NCT01570504 | Strongyloidiasis | Drug: Ivermectin | Centro per le Malattie Tropicali|European Commission | Phase 3 | 2013-03-01 | 2016-08-05 |
| NCT00790998 | Onchocerciasis | Drug: Moxidectin|Drug: Ivermectin | World Health Organization | Phase 3 | 2009-04-01 | 2013-11-26 |
| NCT03052998 | Ivermectin|Onchocerciasis|Epilepsy | Drug: Ivermectin | Robert Colebunders|Universiteit Antwerpen | Phase 4 | 2017-04-01 | 2017-02-15 |
| NCT02046200 | Alcohol Use Disorder | Drug: Ivermectin|Drug: Placebo|Drug: Alcohol | University of California, Los Angeles | Phase 1|Phase 2 | 2014-02-01 | 2016-02-19 |
| NCT00765024 | Chronic Strongyloidiasis | Drug: Ivermectin|Drug: ivermectin|Drug: Albendazole | Mahidol University|Atlantic Laboratory Ltd | Phase 3 | 2008-07-01 | 2010-06-18 |
| NCT01068158 | Head Lice | Drug: 0.5% Ivermectin Cream|Drug: Placebo control | Topaz Pharmaceuticals Inc | Phase 3 | 2010-03-01 | 2012-04-04 |
| NCT00857948 | Pediculus Humanus Capitis (Head Lice) | Drug: ivermectin treatment conditioner|Drug: Placebo, vehicle control | Topaz Pharmaceuticals Inc | Phase 2 | 2009-03-01 | 2012-03-01 |
| NCT00819520 | Lice Infestations | Drug: ivermectin|Drug: malathion | Johnson & Johnson Consumer and Personal Products Worldwide | Phase 3 | 2004-02-01 | 2011-08-19 |
| NCT01066585 | Head Lice | Drug: Ivermectin Cream|Drug: vehicle control | Topaz Pharmaceuticals Inc | Phase 3 | 2010-03-01 | 2012-04-04 |
| NCT02509481 | Malaria|Lymphatic Filariasis | Drug: Ivermectin|Drug: Albendazole | Colorado State University|Institut de Recherche en Sciences de la Sante, Burkina Faso|Centre Muraz|Minist猫re de la Sant茅 du Burkina Faso | Phase 2|Phase 3 | 2015-06-01 | 2016-08-22 |
| NCT01593722 | Loiasis | Drug: Diethylcarbamazine|Drug: Ivermectin | National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC) | Phase 4 | 2012-04-01 | 2016-09-20 |
| NCT00994422 | Head Lice | Drug: Ivermectin cream|Drug: vehicle control | Topaz Pharmaceuticals Inc | Phase 2 | 2009-10-01 | 2012-04-04 |
| NCT02045069 | Dengue Fever | Drug: 2 days Ivermectin|Drug: 3 days Ivermectin|Drug: Placebo | Mahidol University|Ministry of Health, Thailand | Phase 2|Phase 3 | 2014-02-01 | 2015-10-29 |
| NCT02511353 | Malaria | Drug: ivermectin|Drug: placebo|Drug: dihydroartemisinin-piperaquine | Liverpool School of Tropical Medicine|Kenya Medical Research Institute|Centers for Disease Control and Prevention | Phase 2 | 2015-07-01 | 2016-09-06 |
| NCT02407782 | Scabies | Drug: Ivermectin|Drug: Permethrin | University Hospital, Bordeaux | Phase 3 | 2016-01-01 | 2016-06-03 |
